FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes

 
• By Brenda Sandburg
  
Patent skyline
The USPTO and FDA were advised on patent policy changes to prevent unjustified delays in competition • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin